PVLA (Palvella Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on PVLA (Palvella Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

PVLA

Palvella Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Palvella Therapeutics Inc (PVLA) Q3 2025 Earnings Call Highlights: Strategic Advancements and ...
Nov 11, 2025
Palvella Therapeutics: Q3 Earnings Snapshot
Nov 11, 2025
Palvella Therapeutics to Present at the Stifel 2025 Healthcare Conference
Nov 6, 2025
Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025
Nov 4, 2025
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
Oct 13, 2025
Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer
Sep 3, 2025
Palvella Therapeutics to Present at Upcoming Healthcare Investor Conferences
Aug 28, 2025
Palvella Therapeutics: Q2 Earnings Snapshot
Aug 14, 2025
Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025
Aug 7, 2025
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
Aug 5, 2025

Reviews